173 related articles for article (PubMed ID: 12219876)
1. Chronic imidazoline receptor activation in spontaneously hypertensive rats.
Menaouar A; El-Ayoubi R; Jankowski M; Gutkowska J; Mukaddam-Daher S
Am J Hypertens; 2002 Sep; 15(9):803-8. PubMed ID: 12219876
[TBL] [Abstract][Full Text] [Related]
2. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
Mukaddam-Daher S; Gutkowska J
Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
[TBL] [Abstract][Full Text] [Related]
3. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide is involved in renal actions of moxonidine.
Mukaddam-Daher S; Gutkowska J
Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
[TBL] [Abstract][Full Text] [Related]
5. Cardiac effects of moxonidine in spontaneously hypertensive obese rats.
Mukaddam-Daher S; Menaouar A; El-Ayoubi R; Gutkowska J; Jankowski M; Velliquette RA; Ernsberger P
Ann N Y Acad Sci; 2003 Dec; 1009():244-50. PubMed ID: 15028594
[TBL] [Abstract][Full Text] [Related]
6. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
7. Normalization of up-regulated cardiac imidazoline I(1)-receptors and natriuretic peptides by chronic treatment with moxonidine in spontaneously hypertensive rats.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Ann N Y Acad Sci; 2003 Dec; 1009():274-8. PubMed ID: 15028599
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
Cao C; Kang CW; Kim SZ; Kim SH
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
[TBL] [Abstract][Full Text] [Related]
10. Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine.
Penner SB; Smyth DD
Br J Pharmacol; 1994 Aug; 112(4):1089-94. PubMed ID: 7952868
[TBL] [Abstract][Full Text] [Related]
11. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
Prichard BN; Graham BR
Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats.
Mukaddam-Daher S; Menaouar A; Paquette PA; Jankowski M; Gutkowska J; Gillis MA; Shi YF; Calderone A; Tardif JC
Hypertension; 2009 May; 53(5):775-81. PubMed ID: 19273740
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
Prichard BN; Owens CW; Graham BR
J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
[TBL] [Abstract][Full Text] [Related]
14. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
15. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
Penner SB; Smyth DD
Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
[TBL] [Abstract][Full Text] [Related]
16. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
Ernsberger P; Friedman JE; Koletsky RJ
J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
[TBL] [Abstract][Full Text] [Related]
17. Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.
Rupp H; Maisch B; Brilla CG
Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():251-62. PubMed ID: 8827948
[TBL] [Abstract][Full Text] [Related]
18. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
Allan DR; Penner SB; Smyth DD
Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
[TBL] [Abstract][Full Text] [Related]
19. Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
J Pharmacol Exp Ther; 2004 Aug; 310(2):446-51. PubMed ID: 15075383
[TBL] [Abstract][Full Text] [Related]
20. Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation.
Paquette PA; Duguay D; El-Ayoubi R; Menaouar A; Danalache B; Gutkowska J; DeBlois D; Mukaddam-Daher S
Br J Pharmacol; 2008 Feb; 153(3):459-67. PubMed ID: 18059325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
